Latest News

If you are wondering whether DaVita's current share price reflects its true worth, this article walks through how the market might be valuing the business today. DaVita's stock recently closed at US$137.64, with returns of 2.2% over 7 days, 23.5% over 30 days, 20.2% year to date, 66.1% over 3 years and 32.1% over 5 years, set against a 20.8% decline over the last year. Recent headlines around DaVita have focused on its role as a major kidney care provider and on how healthcare policy,...

Why this new 15 year lease matters for Castellum (OM:CAST) investors Castellum (OM:CAST) has signed a 15 year lease covering about 24,000 square metres in its Infinity project in Hagastaden, Stockholm, giving investors an early view of potential future occupancy for the entire property. Construction of Infinity started in autumn 2025, with completion targeted by the end of 2027. The unnamed tenant currently commits to leasing the whole building, subject to an option to reduce the area and the...

Live Oak Bancshares (LOB) is back in focus after quarterly results significantly beat market expectations, followed by an analyst firm lifting its valuation outlook while keeping a positive rating on the stock. See our latest analysis for Live Oak Bancshares. The latest quarterly beat and valuation upgrade come on top of strong momentum, with a 30-day share price return of 13.98% and a 90-day share price return of 30.10%. The 1-year total shareholder return of 15.73% and 3-year total...

Star Bulk Carriers (SBLK) heads into its February 25, 2026 earnings release with expectations for EPS of $0.59, and the market closely watching that projected 73.53% jump versus last year. See our latest analysis for Star Bulk Carriers. The share price at US$23.29 reflects strong recent momentum, with a 30-day share price return of 18.58% and a 1-year total shareholder return of 51.27%, suggesting investors are currently rewarding the earnings outlook more than near term revenue questions. If...

Key Insights Significant control over 5E Advanced Materials by individual investors implies that the general public has...

What financial metrics can indicate to us that a company is maturing or even in decline? A business that's potentially...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Coca-Cola FEMSA. de (NYSE:KOF) has had a great run on the share market with its stock up by a significant 23% over the...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

Why Williams Trading’s estimate cut matters for Crocs (CROX) before earnings Williams Trading’s Sam Poser just cut estimates for Crocs (CROX) ahead of its upcoming fourth quarter earnings, flagging potential consensus misses, weaker Hey Dude sales, and lingering product and pricing issues. See our latest analysis for Crocs. Those concerns come after a choppy run for the shares, with a recent 1 day share price return showing a 2% decline and a 90 day share price return of 12.12%. The 3 year...

If you have been wondering whether Hologic's share price reflects its true worth, this article walks through what the current market price might be saying about value. Hologic recently closed at US$75.02, with returns of 0.4% over the past week, 0.2% over the past month, 0.6% year to date, 15.0% over one year, and longer term returns of a 10.1% decline over three years and a 9.6% decline over five years. Recent news coverage around Hologic has focused on its role in medical technology and...

In late January 2026, MISUMI Group Inc. raised its full-year earnings and dividend guidance for the fiscal year ending March 31, 2026, after reporting higher nine-month sales of ¥320,661 million but lower net income of ¥23,027 million compared with the same period a year earlier. The guidance revision highlights the steady contribution from proprietary initiatives and newly consolidated Fictiv Inc., alongside the earnings impact of a prolonged depreciation of the yen, even as demand from key...

In late January 2026, Micron Technology broke ground on a new advanced wafer fabrication facility in its Singapore NAND complex, a planned US$24.00 billion, 10‑year project that will add 700,000 square feet of cleanroom space to support future NAND demand. The double‑story fab, integrated into Micron’s Singapore NAND Center of Excellence, is designed to co‑locate R&D and manufacturing, improve AI‑driven production efficiencies, and create about 1,600 highly skilled jobs while adhering to...

If you are wondering whether Advanced Micro Devices is still a fair deal after the recent excitement, this article will walk through what the current price might be implying about future expectations. AMD shares last closed at US$216, after a 12.3% decline over the past week, a 6.3% gain over the past month, and returns of 95.5% over 1 year and 159.8% over 3 years. Recent coverage has focused on AMD as a key name in high performance computing and artificial intelligence chips. Investors are...

If you are wondering whether StoneCo shares still offer value after a strong run, this article will walk through what the current price might be telling you. The stock recently closed at US$17.99, with returns of 7.4% over 7 days, 20.8% over 30 days, 22.5% year to date, 88.0% over 1 year and 84.3% over 3 years, compared with a 80.8% decline over 5 years. Recent headlines have focused on StoneCo’s role in Brazil’s digital payments sector and ongoing interest in fintech platforms. This helps...

Mandatum Oyj (HLSE:MANTA) has expanded its credit platform with the launch of Mandatum Credit Opportunities II, an opportunistic European and Nordic credit fund already seeded with over €200 million from institutional and professional investors. See our latest analysis for Mandatum Oyj. At a share price of €6.974, Mandatum Oyj has seen a 90 day share price return of 8.29%, while its 1 year total shareholder return of 61.02% points to firm positive momentum that this new MAMCO II launch may be...

Danaos (DAC) has paired its latest earnings release with a fresh dividend announcement, reporting higher fourth quarter sales and net income alongside a declared US$0.90 per share dividend for common shareholders. See our latest analysis for Danaos. At a share price of US$103.00, Danaos has seen building momentum recently, with a 30 day share price return of 4.32% and a 90 day gain of 9.10%, while its 1 year total shareholder return of 32.24% and 5 year total shareholder return of 235.11%...

In recent days, Cathie Wood’s ARK Invest shifted its crypto exposure by purchasing about 716,030 shares of crypto exchange operator Bullish for roughly US$17.8 million across multiple ETFs while trimming its Coinbase position by a similar dollar amount. This reallocation, made during broader crypto equity weakness and following Bullish’s earnings that exceeded analyst expectations despite ongoing losses, highlights growing institutional interest in the platform’s role within the...

Over the past two weeks, a wave of AI news around NVIDIA has converged: hyperscalers outlined very large 2026 AI capex plans, Samsung moved toward mass-producing HBM4 memory for NVIDIA’s next-generation Vera Rubin accelerators, and multiple new NVIDIA-powered collaborations in robotics, healthcare, education, and scientific computing were announced. Beyond data centers, these partnerships highlight how NVIDIA’s platforms like Isaac, BioNeMo, and Nemotron are increasingly embedded in...

In early February 2026, Eaton reported fourth-quarter and full-year 2025 results showing higher sales, net income and record segment margins, while also issuing 2026 guidance for organic growth of 5% to 7% for the first quarter and 7% to 9% for the full year with earnings per share ranges of US$2.29 to US$2.49 and US$11.57 to US$12.07, respectively. Alongside these results, Eaton expanded its financial flexibility with a new US$8.00 billion senior unsecured delayed draw term loan maturing on...

Edwards Lifesciences (EW) enters a key week for shareholders, with its Q4 2025 earnings release and earnings call scheduled for February 10, 2026, after market close. See our latest analysis for Edwards Lifesciences. At a share price of $76.80, Edwards Lifesciences has seen weaker short term momentum, with a 30 day share price return of 9.79% and a year to date share price return of 10%. The 1 year total shareholder return of 8.02% contrasts with a 5 year total shareholder return of...

IAC (IAC) released fourth quarter and full year 2025 results, with sales and losses from continuing operations both changing versus the prior year, and wrapped up a multi year share repurchase program. See our latest analysis for IAC. IAC’s latest earnings and completion of its multi year buyback come after a mixed stretch in the market, with the share price at US$36.52 showing a 90 day share price return of 8.02% but a 5 year total shareholder return of 74.60% decline. This hints that recent...

Proto Labs, Inc. recently reported record fourth-quarter and full-year 2025 results, with revenue rising to US$136.49 million in Q4 and US$533.13 million for the year, alongside a return to profitability and improved earnings per share. Management is framing 2026 as a transformative year, pairing continued investment in high-growth services like CNC machining and medical-focused capabilities with a disciplined search for acquisitions that fit its digital manufacturing framework. We’ll now...